| |
| |
|
| Insider
Information: |
Hearne Michael S |
| Relationship: |
Chief Financial Officer |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
2,620 |
|
|
Indirect Shares
|
12,767,435 |
|
|
| Direct
Value |
$7,465,690 |
|
|
|
Indirect Value
|
$36,380,806,033 |
|
|
| Total
Shares |
12,770,055 |
|
|
| Total
Value |
$36,388,271,723 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
20
|
3
|
|
Stock
price went up :
|
10
|
0
|
| Stock
price went down : |
10
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-3.0
|
| Percentage
Gain/Loss : |
 -17.1%
|
-97.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Odonate Therapeutics Inc |
ODT |
Chief Financial Officer |
2021-03-15 |
2,620 |
2021-11-19 |
12,767,435 |
Premium* |
|
|
La Jolla Pharmaceutical Co |
LJPC |
Chief Financial Officer |
2022-08-22 |
0 |
2022-08-22 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
145 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
• – – |
2019-01-15 |
4 |
A |
$13.85 |
$554 |
D/D |
40 |
758 |
0 |
- |
|
| ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
• – – |
2019-07-31 |
4 |
A |
$34.64 |
$554 |
D/D |
16 |
1,125 |
0 |
- |
|
| ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
• – – |
2019-09-13 |
4 |
A |
$24.11 |
$555 |
D/D |
23 |
1,188 |
0 |
- |
|
| ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
• – – |
2019-11-29 |
4 |
A |
$29.22 |
$555 |
D/D |
19 |
1,294 |
0 |
- |
|
| ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
• – – |
2020-12-15 |
4 |
A |
$12.91 |
$555 |
D/D |
43 |
2,105 |
0 |
- |
|
| ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
• – – |
2020-01-15 |
4 |
A |
$23.15 |
$556 |
D/D |
24 |
1,360 |
0 |
- |
|
| ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
• – – |
2020-07-31 |
4 |
A |
$30.91 |
$556 |
D/D |
18 |
1,730 |
0 |
- |
|
| ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
• – – |
2020-02-14 |
4 |
A |
$26.73 |
$561 |
D/D |
21 |
1,404 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2020-10-15 |
4 |
A |
$3.32 |
$561 |
D/D |
169 |
169 |
0 |
- |
|
| ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
• – – |
2020-10-15 |
4 |
A |
$13.35 |
$561 |
D/D |
42 |
1,925 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2020-11-13 |
4 |
A |
$3.98 |
$561 |
D/D |
141 |
506 |
0 |
- |
|
| ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
• – – |
2020-11-13 |
4 |
A |
$12.20 |
$561 |
D/D |
46 |
2,017 |
0 |
- |
|
| ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
• – – |
2020-09-15 |
4 |
A |
$13.06 |
$562 |
D/D |
43 |
1,833 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2020-12-15 |
4 |
A |
$3.83 |
$562 |
D/D |
147 |
787 |
0 |
- |
|
| ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
• – – |
2020-03-31 |
4 |
A |
$23.47 |
$563 |
D/D |
24 |
1,479 |
0 |
- |
|
| ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
• – – |
2020-10-30 |
4 |
A |
$12.25 |
$564 |
D/D |
46 |
1,971 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2020-12-31 |
4 |
A |
$3.30 |
$564 |
D/D |
171 |
958 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2020-10-30 |
4 |
A |
$2.89 |
$566 |
D/D |
196 |
365 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2020-11-30 |
4 |
A |
$4.23 |
$566 |
D/D |
134 |
640 |
0 |
- |
|
| ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
• – – |
2019-10-31 |
4 |
A |
$27.00 |
$567 |
D/D |
21 |
1,256 |
0 |
- |
|
| ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
• – – |
2020-03-13 |
4 |
A |
$19.59 |
$568 |
D/D |
29 |
1,455 |
0 |
- |
|
| ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
• – – |
2020-01-31 |
4 |
A |
$24.82 |
$571 |
D/D |
23 |
1,383 |
0 |
- |
|
| ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
• – – |
2020-09-30 |
4 |
A |
$11.42 |
$571 |
D/D |
50 |
1,883 |
0 |
- |
|
| ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
• – – |
2020-11-30 |
4 |
A |
$12.77 |
$575 |
D/D |
45 |
2,062 |
0 |
- |
|
| ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
• – – |
2020-08-31 |
4 |
A |
$13.73 |
$577 |
D/D |
42 |
1,790 |
0 |
- |
|
145 Records found
|
|
Page 2 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
